Yinglong Hou

Yinglong Hou


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 July 2016 in Experimental and Therapeutic Medicine
Verified
Journal Article
Open access
PDF file
LGLing Guo
Ling Guo
HZHongyan Zhang
Hongyan Zhang
YHYinglong Hou
Yinglong Hou
TWTianshu Wei
Tianshu Wei
JLJu Liu
Ju Liu
Endothelial subcellular structures, including caveolae, fenestrae and transendothelial channels, are crucial for regulating microvascular function. Plasmalemma vesicle‑associated protein (PLVAP) is an endothelial cell‑specific protein that forms the stomatal and fenestral diaphragms of blood vessels and regulates basal permeability, leukocyte migration and angiogenesis. Loss of PLVAP in mice leads to premature mortality due to disrupted homeostasis. Evidence from previous studies suggested that PLVAP is involved in cancer, traumatic spinal cord injury, acute ischemic brain disease, transplant glomerulopathy, Norrie disease and diabetic retinopathy. Specifically, PLVAP expression has been demonstrated to be upregulated in these diseases, accompanied by pro‑angiogenic or pro‑inflammatory responses. Therefore, PLVAP is considered a novel therapeutic target, in addition to an endothelial cell marker. The present review summarizes the structure and functions of PLVAP, and its roles in pathophysiological processes.

27 March 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
YZYujiao Zhang
Yujiao Zhang
SZShaohua Zheng
Shaohua Zheng
YGYangyang Geng
Yangyang Geng
JXJiao Xue
Jiao Xue
ZWZhongsu Wang
Zhongsu Wang
YHYinglong Hou
Yinglong Hou
A critical mechanism in atrial fibrillation (AF) is cardiac autonomic nerve remodeling (ANR). MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression at the post-transcriptional level. Numerous miRNAs are involved in diseases of the nervous and cardiovascular systems. We aimed to assess the underlying role of miRNAs in regulating cardiac ANR in AF by right atrial tachypacing (A-TP) in canines. Following 4-week A-TP, the superior left ganglionated plexuses (SLGPs), which are embedded in the fat pads of the left atrium, were subjected to miRNA expression profiling to screen preferentially expressed miRNAs. Sixteen miRNAs showed significantly differential expression between the control and A-TP groups, including miR-206, miR-203, miR-224 and miR-137. In particular, we focused on miR-206, which was elevated ~10-fold in A-TP dogs. Forced expression of miR-206 through lentiviral infection based on A-TP in vivo significantly shortened the atrial effective refractory period (AERP) (81 ± 7 vs. 98 ± 7 ms, P < 0.05). Immunohistochemical analysis showed that the regeneration of nerves increased more than 2-fold by miR-206 overexpression (P < 0.01). The expression of superoxide dismutase 1 (SOD1) was repressed by miR-206 overexpression by Western blot and luciferase assay, indicative of SOD1 as a direct target of miR-206. Overexpression of miR-206 increased reactive oxygen species (ROS) levels in vitro and in vivo, whereas miR-206 silencing attenuated irradiation- or A-TP-induced ROS. Knockdown of SOD1 effectively abolished ROS reduction caused by miR-206 silencing. Our results found the differential expression of miRNAs in response to ANR in AF and elucidated the important role of miR-206 by targeting SOD1. The study illustrated the novel molecular mechanism of ANR and indicated a potential therapeutic target for AF.

26 September 2014 in Biomedical Reports
Verified
Journal Article
Closed access
PDF file
WWWeijie Wang
Weijie Wang
YZYujiao Zhang
Yujiao Zhang
MGMei Gao
Mei Gao
JWJiangrong Wang
Jiangrong Wang
YHYinglong Hou
Yinglong Hou
The present study aimed to investigate the effect of rosuvastatin on atrial structural remodeling in rabbits with myocardial infarction (MI). The rabbits were randomly divided into 4 groups: The sham operation group (S; n=8), the MI group (MI; n=7), the group with low‑dose rosuvastatin [Rs; 2.5 mg/(kg/d), n=7] and the group with high‑dose rosuvastatin [Rl, 5 mg/(kg/d), n=8]. A rabbit MI model was established via ligation of the anterior descending coronary artery. After 8 weeks of intervention, the left atrial diameter (LAD), atrial collagen content, expression level of type Ⅰ collagen and left ventricular ejection fraction (LVEF) were measured. LAD in the MI group was significantly larger than the S, Rs and Rl groups after 8 weeks. The left atrial collagen content of the MI group was also significantly greater than those observed in the other 3 groups. The expression of type Ⅰ collagen in the MI group was significantly increased compared to the other 3 groups. However, LVEF of the MI group was lower compared to the other 3 groups. There were no significant differences between the Rs and Rl groups in the above indexes. In conclusion, rosuvastatin can improve post‑MI atrial structural remodeling.

30 June 2023 in Research Square
Verified
Preprint
Open access
PDF file
XWXuehan Wang
Xuehan Wang
YZYujiao Zhang
Yujiao Zhang
MRManyi Ren
Manyi Ren
JGJing Guo
Jing Guo
ZLZhan Li
Zhan Li
YHYinglong Hou
Yinglong Hou
A growing number of reports have shown that oxidative stress is an important contributing factor for atrial fibrillation (AF). The identification of oxidative stress-related blood biomarkers for patients with AF has great significance for the early prevention and treatment of AF. The purpose of this study was to illuminate the relationship of several blood markers of oxidative stress with AF. This study enrolled hospitalized patients from January 2018 to December 2020 at the Department of Cardiology in a tertiary center in east China.Clinical data, with an emphasis on oxidative stress-related blood biomarkers, were collected to assess their relationship with AF. A total of 9452 patients were enrolled, including 1244 patients with AF (13.16%). Elevated total bilirubin (OR: 1.056; 95% CI: 1.046-1.065; P<0.001), uric acid (OR: 1.157; 95% CI: 1.112-1.204; P<0.001) and reduced superoxide dismutase(OR: 0.992; 95% CI: 0.987-0.997; P=0.001) were significantly associated with AF, which were also effective indicators for diagnosing AF (the area under the ROC curve model combined with uric acid, total bilirubin and superoxide dismutase was 69.1%). Furthermore, oxidative stress-related biomarkers were significantly associated with the prevalence of AF in different ages and sexes. As oxidative stress-related biomarkers, higher levels of total bilirubin and uric acid and lower levels of superoxide dismutase were independently associated with the prevalence of AF. These biomarkers may be used as potential indicators to predict AF, and multitarget antioxidant therapy may be a reasonable approach to prevent and treat AF.